GLIOLAN 30 mg/ml, powder for oral solution bottle, 1.5 g
Active ingredients: ACIDE 5-AMINOLÉVULINIQUE, Aminolevulinic acid hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder for oral solutionbottle, 1.5 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- GLIOLAN 30 mg/ml, poudre pour solution buvable
- Pharmaceutical form
- poudre pour solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre de 1,5 g
- Marketing authorisation holder
- PHOTONAMIC (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Sept 2008
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63389433CIP75732251CIP133400957322519Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACIDE 5-AMINOLÉVULINIQUEpoudre | 1,17 g · un flacon | FT |
| CHLORHYDRATE DE L'ACIDE 5-AMINOLÉVULINIQUEpoudre | 1,5 g · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.